Further investigations on the efficacy of a non-specific defence inducer evaluated in calves exposed to infectious bovine rhinotracheitis virus

G. Castrucci, F. Frigeri, Bennie Osburn, M. Ferrari, F. Barreca, D. Salvatori

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Six calves were given the immunomodulator Baypamun and housed together with another six calves of which, three were experimentally infected with bovine herpesvirus-1 (BHV-1), whereas the remaining three served as untreated controls. The three experimentally infected calves as well as the three controls developed clinical signs of the typical acute form of infectious bovine rhinotracheitis (IBR). Of the calves treated with Baypamun, those that had only one injection of the immunomodulator, either at the start of the experiment (time 0) or 2 days later, underwent a much milder form of IBR and recovered in a shorter time than the experimentally infected calves or the controls. The calves that received four injections of the immunomodulator, i.e. at time 0 and subsequently for the next 3 days, remained healthy throughout the 30 days of observation. Moreover, the virus shedding by the Baypamun treated calves was significantly reduced. It was speculated that the use of an immunomodulator, eventually associated with a vaccination programme, would be a feasible approach to reduce significantly the onset of outbreaks of BHV-1, one of the main infectious agent initiating the respiratory disease in cattle.

Original languageEnglish (US)
Pages (from-to)155-163
Number of pages9
JournalComparative Immunology, Microbiology and Infectious Diseases
Volume21
Issue number2
DOIs
StatePublished - Feb 27 1998

Fingerprint

Bovine Herpesvirus 1
Bovine herpesvirus 1
Immunologic Factors
Infectious Bovine Rhinotracheitis
immunomodulators
calves
infectious bovine rhinotracheitis
Cattle Diseases
Virus Shedding
Injections
Disease Outbreaks
Vaccination
injection
Observation
viral shedding
respiratory tract diseases
Baypamun HK
vaccination
pathogens
cattle

Keywords

  • Calves
  • Immunomodulator
  • Infectious bovine rhinotracheitis

ASJC Scopus subject areas

  • Animal Science and Zoology
  • Immunology
  • Microbiology
  • veterinary(all)

Cite this

Further investigations on the efficacy of a non-specific defence inducer evaluated in calves exposed to infectious bovine rhinotracheitis virus. / Castrucci, G.; Frigeri, F.; Osburn, Bennie; Ferrari, M.; Barreca, F.; Salvatori, D.

In: Comparative Immunology, Microbiology and Infectious Diseases, Vol. 21, No. 2, 27.02.1998, p. 155-163.

Research output: Contribution to journalArticle

@article{83d2ec1a97594d3ba349c21c79d9f8a0,
title = "Further investigations on the efficacy of a non-specific defence inducer evaluated in calves exposed to infectious bovine rhinotracheitis virus",
abstract = "Six calves were given the immunomodulator Baypamun and housed together with another six calves of which, three were experimentally infected with bovine herpesvirus-1 (BHV-1), whereas the remaining three served as untreated controls. The three experimentally infected calves as well as the three controls developed clinical signs of the typical acute form of infectious bovine rhinotracheitis (IBR). Of the calves treated with Baypamun, those that had only one injection of the immunomodulator, either at the start of the experiment (time 0) or 2 days later, underwent a much milder form of IBR and recovered in a shorter time than the experimentally infected calves or the controls. The calves that received four injections of the immunomodulator, i.e. at time 0 and subsequently for the next 3 days, remained healthy throughout the 30 days of observation. Moreover, the virus shedding by the Baypamun treated calves was significantly reduced. It was speculated that the use of an immunomodulator, eventually associated with a vaccination programme, would be a feasible approach to reduce significantly the onset of outbreaks of BHV-1, one of the main infectious agent initiating the respiratory disease in cattle.",
keywords = "Calves, Immunomodulator, Infectious bovine rhinotracheitis",
author = "G. Castrucci and F. Frigeri and Bennie Osburn and M. Ferrari and F. Barreca and D. Salvatori",
year = "1998",
month = "2",
day = "27",
doi = "10.1016/S0147-9571(97)00014-3",
language = "English (US)",
volume = "21",
pages = "155--163",
journal = "Comparative Immunology, Microbiology and Infectious Diseases",
issn = "0147-9571",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Further investigations on the efficacy of a non-specific defence inducer evaluated in calves exposed to infectious bovine rhinotracheitis virus

AU - Castrucci, G.

AU - Frigeri, F.

AU - Osburn, Bennie

AU - Ferrari, M.

AU - Barreca, F.

AU - Salvatori, D.

PY - 1998/2/27

Y1 - 1998/2/27

N2 - Six calves were given the immunomodulator Baypamun and housed together with another six calves of which, three were experimentally infected with bovine herpesvirus-1 (BHV-1), whereas the remaining three served as untreated controls. The three experimentally infected calves as well as the three controls developed clinical signs of the typical acute form of infectious bovine rhinotracheitis (IBR). Of the calves treated with Baypamun, those that had only one injection of the immunomodulator, either at the start of the experiment (time 0) or 2 days later, underwent a much milder form of IBR and recovered in a shorter time than the experimentally infected calves or the controls. The calves that received four injections of the immunomodulator, i.e. at time 0 and subsequently for the next 3 days, remained healthy throughout the 30 days of observation. Moreover, the virus shedding by the Baypamun treated calves was significantly reduced. It was speculated that the use of an immunomodulator, eventually associated with a vaccination programme, would be a feasible approach to reduce significantly the onset of outbreaks of BHV-1, one of the main infectious agent initiating the respiratory disease in cattle.

AB - Six calves were given the immunomodulator Baypamun and housed together with another six calves of which, three were experimentally infected with bovine herpesvirus-1 (BHV-1), whereas the remaining three served as untreated controls. The three experimentally infected calves as well as the three controls developed clinical signs of the typical acute form of infectious bovine rhinotracheitis (IBR). Of the calves treated with Baypamun, those that had only one injection of the immunomodulator, either at the start of the experiment (time 0) or 2 days later, underwent a much milder form of IBR and recovered in a shorter time than the experimentally infected calves or the controls. The calves that received four injections of the immunomodulator, i.e. at time 0 and subsequently for the next 3 days, remained healthy throughout the 30 days of observation. Moreover, the virus shedding by the Baypamun treated calves was significantly reduced. It was speculated that the use of an immunomodulator, eventually associated with a vaccination programme, would be a feasible approach to reduce significantly the onset of outbreaks of BHV-1, one of the main infectious agent initiating the respiratory disease in cattle.

KW - Calves

KW - Immunomodulator

KW - Infectious bovine rhinotracheitis

UR - http://www.scopus.com/inward/record.url?scp=0031970993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031970993&partnerID=8YFLogxK

U2 - 10.1016/S0147-9571(97)00014-3

DO - 10.1016/S0147-9571(97)00014-3

M3 - Article

C2 - 9611684

AN - SCOPUS:0031970993

VL - 21

SP - 155

EP - 163

JO - Comparative Immunology, Microbiology and Infectious Diseases

JF - Comparative Immunology, Microbiology and Infectious Diseases

SN - 0147-9571

IS - 2

ER -